Sofia, Bulgaria, June 25, 2025 – “Sopharma” AD has announced the sale of 1,000 repurchased own shares. This transaction was completed on June 24, 2025. The shares sold represent 0.001% of the company’s share capital.
The total value of the shares sold amounted to BGN 6,640.00 with an average price per share of BGN 6.64 on the Bulgarian Stock Exchange.
Following this transaction, “Sopharma” AD now holds a total of 12,931,782 treasury shares which constitute 7.19% of its share capital.
Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…
The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.
Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…
Sign-up for the Weekly Newsletter from EU Business Daily.